Skip to main content
CVS
NYSE Life Sciences

CVS 达成拟议的联邦贸易委员会(FTC)关于胰岛素定价的和解协议,待最终条款确定

feedReported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$71.58
Mkt Cap
$91.065B
52W Low
$58.35
52W High
$85.15
Market data snapshot near publication time

summarizeSummary

CVS Health 已与联邦贸易委员会(FTC)就胰岛素定价达成拟议的和解协议。虽然最终条款仍待确定,预计将在未来几周内确认,但这一发展表明在解决一个重大监管问题方面取得了进展。这是在 CVS 的 Aetna 子公司最近与美国司法部就无关指控达成 1.177 亿美元和解协议之后发生的。解决 FTC 对高调问题如胰岛素定价的监管审查,可以减少公司的法律和运营不确定性。交易者将密切关注最终条款,以评估任何财务影响或对业务实践的必要变化。

在该公告发布时,CVS的交易价格为$71.58,交易所为NYSE,所属行业为Life Sciences,市值约为$910.6亿。 52周交易区间为$58.35至$85.15。 这则新闻被评估为中性市场情绪,重要性评分为7/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed CVS - Latest Insights

CVS
Apr 24, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
7
CVS
Apr 16, 2026, 12:53 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CVS
Apr 09, 2026, 5:40 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CVS
Apr 03, 2026, 4:05 PM EDT
Filing Type: DEFA14A
Importance Score:
7
CVS
Apr 03, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CVS
Apr 01, 2026, 3:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CVS
Mar 30, 2026, 1:12 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CVS
Mar 30, 2026, 2:47 AM EDT
Source: ShareCast
Importance Score:
8
CVS
Mar 24, 2026, 12:34 PM EDT
Source: Reuters
Importance Score:
7
CVS
Mar 19, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7